Watch Demo

Global Acne Market: Industry Analysis & Outlook (2017-2021)

Global Acne Market: Industry Analysis & Outlook (2017-2021)

  • Publish Date:January 2018

  • Number of Pages:77

  • Report ID:5281471

  • Format:PDF

  • Publisher:Koncept Analytics

$ 800

Summary

Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed.

There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the face, but can also be a nuisance on chest, back, and upper arms. Although usually not considered a dangerous medical condition, acne can cause psychological distress and even skin scarring. Teenagers are the most commonly affected group with around 85% of 16-18 year olds believed to have some form of acne. However, some people may suffer from acne well into their 30s and 40s even.

The global acne market is set to experience favorable growth driven by factors such as increasing youth population, upsurge in disposable income, rising health care expenditure and growing sedentary lifestyle. The major trends observed in this market include technological advancements, rising preference for minimally invasive procedures and increasing awareness programs about acne. However, the growth of this market is constrained by challenges such as entry of generic drugs, side effects of acne therapies and stringent regulations.

The report “Global Acne Market: Industry Analysis & Outlook (2017-2021)” analyses the development of the market, with focus on the US and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Valeant Pharmaceuticals International, Inc., Reckitt Benckiser Group Plc., Allergan Plc. And GlaxoSmithKline Plc. are being profiled along with their key financials and strategies for growth.

Table of contents

1. Overview
1.1 Introduction
1.2 Causes and Symptoms
1.3 Severity of Acne
1.4 Treatment

2. Global Acne Market
2.1 Global Acne Market Forecast by Value
2.2 Global Acne Market by Type
2.2.1 Global Inflammatory Acne Market Forecast by Value
2.2.2 Global Non-Inflammatory Acne Market Forecast by Value
2.3 Global Acne Patient Volume Forecast

3. Regional Market Analysis
3.1 The US
3.1.1 The US Acne Market Forecast by Value
3.1.2 The US Acne Market by Drug Type
3.1.3 The US Acne Topical Drugs by Brand
3.1.4 The US Acne Oral Antibiotics by Brand
3.1.5 The US Moderate to Severe Market Forecast by Value
3.1.6 The US Topical Retinoid Market Forecast by Value
3.1.7 The US Isotretinoin Market Forecast by Value
3.1.8 The US Minocycline Market Forecast by Value
3.1.9 The US Moderate to Severe Annual Prescriptions Forecast
3.1.10 The US Topical Retinoid Annual Prescriptions Forecast
3.1.11 The US Isotretinoin Annual Prescriptions Forecast
3.1.12 The US Minocycline Annual Prescriptions Forecast
3.1.13 The US Acne Patient Volume Forecast
3.1.14 The US Moderate to Severe Acne Patient Volume Forecast
3.1.15 The US Acne Treated Patient Volume Forecast
3.2 The US Acne Drugs Revenue
3.2.1 The US FMX-101 Drug Revenue Forecast
3.2.2 The US SNA-001 Drug Revenue Forecast
3.2.3 The US DRM-01 Drug Revenue Forecast
3.3 Europe
3.3.1 Europe Acne Patient Volume Forecast
3.3.2 Europe Moderate to Severe Acne Patient Volume Forecast
3.3.3 Europe Acne Treated Patient Volume Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Youth Population
4.1.2 Upsurge in Disposable Income
4.1.3 Rising HealthCare Expenditure
4.1.4 Growing Sedentary Lifestyle

4.2 Key Trends & Developments
4.2.1 Technological Advancements
4.2.2 Rising Preference for Minimally Invasive Procedures
4.2.3 Increasing Awareness Programs

4.3 Challenges
4.3.1 Entry of Generic Drugs
4.3.2 Side Effects of Acne Therapies
4.3.3 Stringent Regulations

5. Competitive Landscape
5.1 Global Market
5.1.1 Global Acne Market- Revenue and Market Cap Comparison
5.1.2 Global Acne Market- Drug Comparison by Company
5.1.3 Global Late Stage Acne Market- Drug Comparison by Company
5.1.4 Global Mid Stage Acne Market- Drug Comparison by Company

6. Company Profiles
6.1 Valeant Pharmaceuticals International, Inc.
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies

6.2 Reckitt Benckiser Group Plc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies

6.3 Allergan Plc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies

6.4 GlaxoSmithKline Plc.
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

List of Charts
Types of Acne
Treatment for Acne
Global Acne Market Forecast by Value (2016-2021)
Global Acne Market by Type (2016)
Global Inflammatory Acne Market Forecast by Value (2016-2021)
Global Non-Inflammatory Acne Market Forecast by Value (2016-2021)
Global Acne Patient Volume Forecast (2016-2021)
The US Acne Market Forecast by Value (2016-2021)
The US Acne Market by Drug Type (2016)
The US Acne Topical Drugs by Brand (2016)
The US Acne Oral Antibiotics by Brand (2016)
The US Moderate to Severe Acne Market Forecast by Value (2016-2021)
The US Topical Retinoid Market Forecast by Value (2016-2021)
The US Isotretinoin Market Forecast by Value (2016-2021)
The US Minocycline Market Forecast by Value (2016-2021)
The US Moderate to Severe Annual Prescriptions Forecast (2016-2021)
The US Topical Retinoid Annual Prescriptions Forecast (2016-2021)
The US Isotretinoin Annual Prescriptions Forecast (2016-2021)
The US Minocycline Annual Prescriptions Forecast (2016-2021)
The US Acne Patient Volume Forecast (2016-2021)
The US Moderate to Severe Acne Patient Volume Forecast (2016-2021)
The US Acne Treated Patient Volume Forecast (2016-2021)
The US FMX-101 Drug Revenue Forecast (2020-2024)
The US SNA-001 Drug Revenue Forecast (2020-2024)
The US DRM-01 Drug Revenue Forecast (2020-2024)
Europe Acne Patient Volume Forecast (2016-2021)
Europe Moderate to Severe Acne Patient Volume Forecast (2016-2021)
Europe Acne Treated Patient Volume Forecast (2016-2021)
Global Youth Population (2010-2025)
Global GNI Per Capita (2012-2016)
Global HealthCare Expenditure Per Capita (2012-2016)
Valeant Pharmaceuticals Revenue by Segments (2016)
Valeant Pharmaceuticals Revenue and Net Loss (2012-2016)
Valeant Pharmaceuticals Research & Development Expenses (2014-2016)
Reckitt Benckiser Revenue by Segments (2016)
Reckitt Benckiser Revenue and Net Income (2012-2016)
Reckitt Benckiser R&D Expenses (2014-2016)
Allergan Plc. Revenue by Segment (2016)
Allergan Plc. Revenue and Net Income (2012-2016)
Allergan Plc. R&D Expenses (2013-2016)
GlaxoSmithKline Plc. Revenue by Segments (2016)
GlaxoSmithKline Plc. Revenue and Net Profit (2012-2016)

List of Tables
Global Acne Market - Revenue & Market Cap Comparison (2016)
Global Acne Market- Drug Comparison by Company (2016)
Global Late Stage Acne Market- Drug Comparison by Company (2016)
Global Mid Stage Acne Market- Drug Comparison by Company (2016)
Valeant Pharmaceuticals Agreements (2017)

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.